Saboyá-Díaz Martha-Idalí, Castellanos Luis Gerardo, Morice Ana, Ade Maria Paz, Rey-Benito Gloria, Cooley Gretchen M, Scobie Heather M, Wiegand Ryan E, Coughlin Melissa M, Martin Diana L
Pan American Health Organization Washington, D.C. United States of America Pan American Health Organization, Washington, D.C., United States of America.
Centers for Disease Control and Prevention Atlanta United States of America Centers for Disease Control and Prevention, Atlanta, United States of America.
Rev Panam Salud Publica. 2023 Mar 7;47:e53. doi: 10.26633/RPSP.2023.53. eCollection 2023.
Systematize the experience and identify challenges and lessons learned in the implementation of an initiative for integrated serosurveillance of communicable diseases using a multiplex bead assay in countries of the Americas.
Documents produced in the initiative were compiled and reviewed. These included concept notes, internal working papers, regional meetings reports, and survey protocols from the three participating countries (Mexico, Paraguay, and Brazil) and two additional countries (Guyana and Guatemala) where serology for several communicable diseases was included in neglected tropical diseases surveys. Information was extracted and summarized to describe the experience and the most relevant challenges and lessons learned.
Implementing integrated serosurveys requires interprogrammatic and interdisciplinary work teams for the design of survey protocols to respond to key programmatic questions aligned to the needs of the countries. Valid laboratory results are critical and rely on the standardized installment and roll-out of laboratory techniques. Field teams require adequate training and supervision to properly implement survey procedures. The analysis and interpretation of serosurveys results should be antigen-specific, contextualizing the responses for each disease, and triangulated with programmatic and epidemiological data for making decisions tailored to specific population socioeconomic and ecologic contexts.
Integrated serosurveillance as a complementary tool for functional epidemiological surveillance systems is feasible to use and key components should be considered: political engagement, technical engagement, and integrated planning. Aspects such as designing the protocol, selecting target populations and diseases, laboratory capacities, anticipating the capacities to analyze and interpret complex data, and how to use it are key.
梳理在美洲国家使用多重微珠分析开展传染病综合血清学监测倡议实施过程中的经验,确定挑战及汲取的教训。
汇编并审查该倡议产生的文件。这些文件包括概念说明、内部工作文件、区域会议报告以及来自三个参与国(墨西哥、巴拉圭和巴西)和另外两个国家(圭亚那和危地马拉)的调查方案,在这些国家的被忽视热带病调查中纳入了几种传染病的血清学检测。提取并总结信息以描述经验以及最相关的挑战和汲取的教训。
实施综合血清学调查需要跨项目和跨学科的工作团队来设计调查方案,以回应与各国需求相符的关键项目问题。有效的实验室结果至关重要,且依赖于实验室技术的标准化安装和推广。实地团队需要充分的培训和监督,以正确实施调查程序。血清学调查结果的分析和解释应针对抗原,结合每种疾病的反应情况,并与项目和流行病学数据进行三角验证,以便针对特定人群的社会经济和生态背景做出决策。
作为功能性流行病学监测系统的补充工具,综合血清学监测是可行的,应考虑关键组成部分:政治参与、技术参与和综合规划。诸如设计方案、选择目标人群和疾病、实验室能力、预测分析和解释复杂数据的能力以及如何使用等方面是关键。